Translation of "translation of aux prises disponibles " (French → English) :

Question No. 1 Hon. Irwin Cotler: With regard to aboriginal justice, broken down by year from 2006 to the present: (a) how much money was dedicated to the Aboriginal Justice Strategy (AJS); (b) how much money was devoted to other aboriginal justice programs; (c) with respect to (a) and (b), by program, how much money was spent; (d) by whom were monies in (a) and (b) spent, on what dates, and for what purpose; (e) broken down by province and territory, on what dates were provinces and territories consulted with respect to funding of the AJS for the upcoming year; (f) broken down by province and territory, on what dates were the provi ...[+++]nces and territories consulted with respect to other aboriginal justice programs; (g) broken down by province and territory, how much did each request of the government with respect to the AJS; (h) broken down by province and territory, with which First Nations did the government consult with respect to the AJS; (i) with which First Nations groups and non-governmental organizations (NGOs) did the government consult with respect to the AJS; (j) with which other stakeholders did the government consult with respect to the AJS; (k) which stakeholders were informed of budget decisions relative to the AJS, by what means and on what dates; (l) broken down by province and territory, how much did each request of the government with respect to other aboriginal justice programs; (m) broken down by province and territory, with which First Nations did the government consult with respect to other aboriginal justice programs; (n) with which First Nations groups and NGOs did the government consult with respect to other aboriginal justice programs; (o) with which other stakeholders did the government consult with respect to other aboriginal justice programs; (p) how does the government determine stakeholders regarding aboriginal justice concerns; (q) by whom, with what criteria, and when was the AJS budget determined; (r) in what ways, by ...

The second shortcoming is that the rules could prevent industry from taking advantage of increases in available catches from stocks that have recovered.

(Return tabled) Question No. 424 Ms. Kirsty Duncan: With regard to the current pandemic of new influenza A (H1N1) virus in Aboriginal (First Nations, Inuit, Metis) communities in Canada: (a) what were the containment measures taken to slow the spread of the virus within households, between households, and among communities; (b) what were the control measures taken in more remote areas to flatten the epidemiological peak; (c) what was the average length of time from symptoms to treatment for those Aboriginal peoples who required a stay in intensive care unit (ICU); (d) what percentage of hospitalizations, ICU cases, and deaths were amo ...[+++]ng Aboriginal peoples, and how do these compare with the Canadian population at large; (e) what was the average length of time on a ventilator and the mean length of stay in an ICU for Aboriginal peoples; (f) what specific measures are being planned to reduce the time to treatment, hospitalizations, ICU, and deaths; (g) when will the results of the preliminary investigation in First Nations communities be available, specifically, (i) how many Aboriginal communities in Canada have a revised H1N1 pandemic influenza plan, (ii) how many have tested their plan, (iii) how many have necessary supplies in place; (h) what specific actions have been undertaken to address the fact that only two of 30 communities in northern Manitoba had a pandemic plan, and none had been tested; (i) where did the Minister of Health obtain the 90 percent figure she used in her August 28 response letter to Drs Bennett and Duncan; (j) what funding have Aboriginal communities requested, and what additional funds have been made available to Aboriginal communities for pandemic planning and response in 2009; (k) is there any encouragement to identify vulnerable people, such as pregnant women and those with underlying medical conditions, to take additional precautions, specifically, (i) how many communities lack necessary clean water for infection control measur ...

As regards the Government's claim that all its positions can be found on the website of the Ministry of Agriculture they observe that it is only the final position paper which appears on the website.

If the absence of certain scientific data makes it impossible to characterise the risk, taking into account the uncertainties inherent to the evaluation, the measures taken under the precautionary principle should be comparable in nature and scope with measures already taken in equivalent areas in which all the scientific data are available.

Q-91 Mr. Cummins (Delta South Richmond) With reference to the antimalarial drug mefloquine administered to Canadian Forces bound for Somalia in 1992-93 and the legal framework under which it was available for use and administered: (a) was mefloquine a licensed drug when it was administered to Canadian Forces, if not what was its status, and how was it legally available; (b) were the Canadian Forces participating in the Lariam (mefloquine) Safety Monitoring Study during this period; (c) was the mefloquine administered in accordance with the Lariam Safety Monitoring Study and the Food and Drugs Act; (d) who was the " principal investigator" responsible for the L ...[+++]ariam Safety Monitoring Study in the Canadian Forces; (e) who was the Canadian Forces physician responsible to the " principal investigator" of the Lariam Safety Monitoring Study; (f) what was the role of Canadian Forces physician, Dr. Martin Tepper, in the Lariam Safety Monitoring Study; (g) who was responsible for the Lariam Safety Monitoring Study at the Department of Health's Health Protection Branch during this period; (h) what was the role and responsibility of the Health Protection Branch under the Lariam Safety Monitoring Study and the Food and Drugs Act and its regulations in regard to the use of mefloquine by Canadian Forces personnel; (i) when did the Health Protection Branch become aware that mefloquine was being administered to Canadian Forces personnel bound for Somalia; (j) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act prior to the licensing of mefloquine to inform the manufacturer of its use; (k) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act to the soldiers who were administered the drug; (l) did the Canadian Forces fulfil their responsibility to the manufacturer under the Lariam Safety Monitoring Study and the Food and Dru ...